The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
The Relationship of the Factor V Leiden Mutation and Pregnancy Outcomes for Mother and Fetus
Abstract
OBJECTIVE: We sought to estimate the frequency of pregnancy-related thromboembolic events among carriers of the factor V Leiden (FVL) mutation without a personal history of thromboembolism, and to evaluate the impact of maternal and fetal FVL mutation carriage or other thrombophilias on the risk of adverse outcomes. METHODS: Women with a singleton pregnancy and no history of thromboembolism were recruited at 13 clinical centers before 14 weeks of gestation from April 2000 to August 2001. Each was tested for the FVL mutation, as was the resultant conceptus after delivery or after miscarriage, when available. The incidence of thromboembolism (primary outcome), and of other adverse outcomes, was compared between FVL mutation carriers and noncarriers. We also compared adverse outcomes in a secondary nested carrier-control analysis of FVL mutation and other coagulation abnormalities. In this secondary analysis, we defined carriers as women having one or more of the following traits: carrier for FVL mutation, protein C deficiency, protein S deficiency, antithrombin III deficiency, activated protein C resistance, or lupus anticoagulant-positive, heterozygous for prothrombin G20210A or homozygous for the 5,10 methylenetetrahydrofolate reductase mutations. Carriers of the FVL mutation alone (with or without activated protein C resistance) were compared with those having one or more other coagulation abnormalities and with controls with no coagulation abnormality. RESULTS: One hundred thirty-four FVL mutation carriers were identified among 4,885 gravidas (2.7%), with both FVL mutation status and pregnancy outcomes available. No thromboembolic events occurred among the FVL mutation carriers (0%, 95% confidence interval 0-2.7%). Three pulmonary emboli and one deep venous thrombosis occurred (0.08%, 95% confidence interval 0.02-0.21%), all occurring in FVL mutation noncarriers. In the nested carrier-control analysis (n = 339), no differences in adverse pregnancy outcomes were observed between FVL mutation carriers, carriers of other coagulation disorders, and controls. Maternal FVL mutation carriage was not associated with increased pregnancy loss, preeclampsia, placental abruption, or small for gestational age births. However, fetal FVL mutation carriage was associated with more frequent preeclampsia among African-American (15.0%) and Hispanic (12.5%) women than white women (2.6%, P = .04), adjusted odds ratio 2.4 (95% confidence interval 1.0-5.2, P = .05). CONCLUSION: Among women with no history of thromboembolism, maternal heterozygous carriage of the FVL mutation is associated with a low risk of venous thromboembolism in pregnancy. Neither universal screening for the FVL mutation, nor treatment of low-risk carriers during pregnancy is indicated. LEVEL OF EVIDENCE: II-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation in blood coagulation factor V associated with resistance to activated protein C
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P. A., & Reitsma, P. H. (1994) · Nature · doi:10.1038/369064a0 · Cited by 3,783
A united states national reference for fetal growth
ALEXANDER, G., HIMES, J., KAUFMAN, R., MOR, J., & KOGAN, M. (1996) · Obstetrics & Gynecology · doi:10.1016/0029-7844(95)00386-x · Cited by 2,294
Increased Frequency of Genetic Thrombophilia in Women with Complications of Pregnancy
Kupferminc, M. J., Eldor, A., Steinman, N., Many, A., Bar-Am, A., Jaffa, A., Fait, G., & Lessing, J. B. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400102 · Cited by 956
Increased frequency of genetic thrombophilia in women with complications of pregnancy
(1999) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(99)80075-3 · Cited by 832
Increased fetal loss in women with heritable thrombophilia
Preston, F., Rosendaal, F., Walker, I., Briët, E., Berntorp, E., Conard, J., Fontcuberta, J., Makris, M., Mariani, G., Noteboom, W., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04125-6 · Cited by 661
Gerhardt, A., Scharf, R. E., Beckmann, M. W., Struve, S., Bender, H. G., Pillny, M., Sandmann, W., & Zotz, R. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420602 · Cited by 491
Pregnancy-related mortality in the United States, 1991–1997
Berg, C. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02587-5 · Cited by 461
Risk Factors for Pregnancy Associated Venous Thromboembolism
McColl, M. D., Ramsay, J. E., Tait, R. C., Walker, I. D., McCall, F., Conkie, J. A., Carty, M. J., & Greer, I. A. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657712 · Cited by 426
The factor V Leiden mutation may predispose women to severe preeclampsia
Dizon-Townson, D. S., Nelson, L. M., Easton, K., & Ward, K. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)80022-6 · Cited by 271
Self-citationFactor V Leiden Is Associated with Repeated and Recurrent Unexplained Fetal Losses
Grandone, E., Margaglione, M., Colaizzo, D., d'Addedda, M., Cappucci, G., Vecchione, G., Sciannamé, N., Pavone, G., & Di Minno, G. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656060 · Cited by 261
Cited by
Steegers, E. A., von Dadelszen, P., Duvekot, J. J., & Pijnenborg, R. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60279-6 · Cited by 2,850
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Evaluation and treatment of recurrent pregnancy loss: a committee opinion
(2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.06.048 · Cited by 1,308
Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Pabinger, I., Sofaer, S., & Hirsh, J. (2008) · Chest · doi:10.1378/chest.08-0761 · Cited by 793
Melamed, N., Baschat, A., Yinon, Y., Athanasiadis, A., Mecacci, F., Figueras, F., Berghella, V., Nazareth, A., Tahlak, M., McIntyre, H. D., et al. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13522 · Cited by 570
Metadata
- Authors
- Dizon-Townson, D., Miller, C., Sibai, B., Spong, C. Y., Thom, E., Wendel, G., Wenstrom, K., Samuels, P., Cotroneo, M. A., Moawad, A., Sorokin, Y., Meis, P., Miodovnik, M., O’Sullivan, M. J., Conway, D., Wapner, R. J., & Gabbe, S. G.
- Venue
- Obstetrics & Gynecology
- Published
- 2005-09
- Volume
- 106
- Issue
- 3
- Pages
- 517-524
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W2049682361
- Cited by
- 257
- References
- 22
- FWCI
- 8.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Relationship of the Factor V Leiden Mutation and Pregnancy Outcomes for Mother and Fetus. https://app.cochat.ai/papers/10.1097/01.aog.0000173986.32528.ca
- The paper
- Dizon-Townson, D., Miller, C., Sibai, B., Spong, C. Y., Thom, E., Wendel, G., Wenstrom, K., Samuels, P., Cotroneo, M. A., Moawad, A., Sorokin, Y., Meis, P., Miodovnik, M., O’Sullivan, M. J., Conway, D., Wapner, R. J., & Gabbe, S. G. (2005). The Relationship of the Factor V Leiden Mutation and Pregnancy Outcomes for Mother and Fetus. Obstetrics & Gynecology. https://doi.org/10.1097/01.aog.0000173986.32528.ca
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.